Earnings Per Share - Summary of Calculation of Basic and Diluted EPS (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Basic earnings per share
Net income (loss) attributable to the Company		$ 16,198	$ 13,262	$ 20,992	$ (5,267)
Less: Earnings allocable to unvested restricted stock		(333)	(305)	(852)	(837)
Net income (loss) attributable to common shareholders		$ 15,865	$ 12,957	$ 20,140	$ (6,104)
Weighted-average basic shares outstanding		30,756	31,305	31,149	31,307
Net income (loss) per share attributable to common shareholders		$ 0.52	$ 0.41	$ 0.65	$ (0.19)
Diluted earnings per share
Net income (loss) attributable to common shareholders	[1]	$ 15,865	$ 12,957	$ 20,140	$ (6,104)
Weighted-average diluted shares	[1]	30,756	31,305	31,151	31,307
Net income (loss) per share attributable to common shareholders	[1]	$ 0.52	$ 0.41	$ 0.65	$ (0.19)

[1] For the nine months ended September 30, 2024, the computation of diluted EPS includes contingently issuable shares related to PSUs calculated under the treasury stock method. For the three and nine months ended September 30, 2024, the computation of diluted EPS does not include contingently issuable shares related to unvested restricted stock awards due to their anti-dilutive nature. For the three and nine months ended September 30, 2024, had the contingently issuable shares been dilutive, the denominator for diluted EPS would have been 30,940 and 31,224, respectively, including 184 and 73, respectively, contingently issuable shares related to unvested restricted stock awards. For the three and nine months ended September 30, 2023, the computation of diluted EPS does not include contingently issuable shares related to unvested restricted stock awards due to their anti-dilutive nature. For the three and nine months ended September 30, 2023, had the contingently issuable shares been dilutive, the denominator for diluted EPS would have been 31,334 and 31,320, respectively, including 29 and 13, respectively, contingently issuable shares related to unvested restricted stock awards.